Literature DB >> 22541855

Perceived impact of the Medicare policy to adjust payment for health care-associated infections.

Grace M Lee1, Christine W Hartmann, Denise Graham, William Kassler, Maya Dutta Linn, Sarah Krein, Sanjay Saint, Donald A Goldmann, Scott Fridkin, Teresa Horan, John Jernigan, Ashish Jha.   

Abstract

BACKGROUND: In 2008, the Centers for Medicare and Medicaid Services (CMS) ceased additional payment for hospitalizations resulting in complications deemed preventable, including several health care-associated infections. We sought to understand the impact of the CMS payment policy on infection prevention efforts.
METHODS: A national survey of infection preventionists from a random sample of US hospitals was conducted in December 2010.
RESULTS: Eighty-one percent reported increased attention to HAIs targeted by the CMS policy, whereas one-third reported spending less time on nontargeted HAIs. Only 15% reported increased funding for infection control as a result of the CMS policy, whereas most reported stable (77%) funding. Respondents reported faster removal of urinary (71%) and central venous (50%) catheters as a result of the CMS policy, whereas routine urine and blood cultures on admission occurred infrequently (27% and 13%, respectively). Resource shifting (ie, less time spent on nontargeted HAIs) occurred more commonly in large hospitals (odds ratio, 2.3; 95% confidence interval: 1.0-5.1; P = .038) but less often in hospitals where front-line staff were receptive to changes in clinical processes (odds ratio, 0.5; 95% confidence interval: 0.3-0.8; P = .005).
CONCLUSION: Infection preventionists reported greater hospital attention to preventing targeted HAIs as a result of the CMS nonpayment policy. Whether the increased focus and greater engagement in HAI prevention practices has led to better patient outcomes is unclear.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541855      PMCID: PMC3998719          DOI: 10.1016/j.ajic.2011.11.003

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  27 in total

Review 1.  The influence of context on quality improvement success in health care: a systematic review of the literature.

Authors:  Heather C Kaplan; Patrick W Brady; Michele C Dritz; David K Hooper; W Matthew Linam; Craig M Froehle; Peter Margolis
Journal:  Milbank Q       Date:  2010-12       Impact factor: 4.911

2.  CMS changes in reimbursement for HAIs: setting a research agenda.

Authors:  Patricia W Stone; Sherry A Glied; Peter D McNair; Nikolas Matthes; Bevin Cohen; Timothy F Landers; Elaine L Larson
Journal:  Med Care       Date:  2010-05       Impact factor: 2.983

3.  Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality?

Authors:  Robert McNutt; Tricia J Johnson; Richard Odwazny; Zachary Remmich; Kimberly Skarupski; Steven Meurer; Samuel Hohmann; Brian Harting
Journal:  Qual Manag Health Care       Date:  2010 Jan-Mar       Impact factor: 0.926

4.  Strategies to prevent catheter-associated urinary tract infections in acute care hospitals.

Authors:  Evelyn Lo; Lindsay Nicolle; David Classen; Kathleen M Arias; Kelly Podgorny; Deverick J Anderson; Helen Burstin; David P Calfee; Susan E Coffin; Erik R Dubberke; Victoria Fraser; Dale N Gerding; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Jonas Marschall; Leonard A Mermel; David A Pegues; Trish M Perl; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

5.  Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure.

Authors:  Robert M Wachter; Scott A Flanders; Christopher Fee; Peter J Pronovost
Journal:  Ann Intern Med       Date:  2008-07-01       Impact factor: 25.391

6.  Medicare's policy not to pay for treating hospital-acquired conditions: the impact.

Authors:  Peter D McNair; Harold S Luft; Andrew B Bindman
Journal:  Health Aff (Millwood)       Date:  2009 Sep-Oct       Impact factor: 6.301

7.  Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy.

Authors:  Jennifer Meddings; Sanjay Saint; Laurence F McMahon
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

8.  The influence of organizational context on quality improvement and patient safety efforts in infection prevention: a multi-center qualitative study.

Authors:  Sarah L Krein; Laura J Damschroder; Christine P Kowalski; Jane Forman; Timothy P Hofer; Sanjay Saint
Journal:  Soc Sci Med       Date:  2010-09-28       Impact factor: 4.634

9.  Catheter-associated urinary tract infection and the Medicare rule changes.

Authors:  Sanjay Saint; Jennifer A Meddings; David Calfee; Christine P Kowalski; Sarah L Krein
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

10.  Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.

Authors:  Brian Serumaga; Dennis Ross-Degnan; Anthony J Avery; Rachel A Elliott; Sumit R Majumdar; Fang Zhang; Stephen B Soumerai
Journal:  BMJ       Date:  2011-01-25
View more
  9 in total

Review 1.  Infection Prevention in the Hospital from Past to Present: Evolving Roles and Shifting Priorities.

Authors:  Michelle Doll; Angela L Hewlett; Gonzalo Bearman
Journal:  Curr Infect Dis Rep       Date:  2016-05       Impact factor: 3.725

2.  HAC-POA policy effects on hospitals, other payers, and patients.

Authors:  Asta Sorensen; Nikki Jarrett; Elizabeth Tant; Shulamit Bernard; Nancy McCall
Journal:  Medicare Medicaid Res Rev       Date:  2014-10-02

3.  Attributable cost and length of stay for central line-associated bloodstream infections.

Authors:  Anthony Goudie; Linda Dynan; Patrick W Brady; Mallikarjuna Rettiganti
Journal:  Pediatrics       Date:  2014-05-05       Impact factor: 7.124

4.  Hospital-Acquired Condition Rate of Admitting Facility Does Not Predict Mortality in Traumatically Injured Patients.

Authors:  Christopher B Horn; Joseph F O'Malley; Evan P Carey; John T Culhane
Journal:  Cureus       Date:  2022-04-07

5.  The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research.

Authors:  Nasia Safdar; Deverick J Anderson; Barbara I Braun; Philip Carling; Stuart Cohen; Curtis Donskey; Marci Drees; Anthony Harris; David K Henderson; Susan S Huang; Manisha Juthani-Mehta; Ebbing Lautenbach; Darren R Linkin; Jennifer Meddings; Loren G Miller; Aaron Milstone; Daniel Morgan; Sharmila Sengupta; Meera Varman; Deborah Yokoe; Danielle M Zerr
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05       Impact factor: 3.254

6.  Comparison of hospital surgical site infection rates and rankings using claims versus National Healthcare Safety Network surveillance data.

Authors:  Chanu Rhee; Rui Wang; Maximilian S Jentzsch; Carly Broadwell; Heather Hsu; Robert Jin; Kelly Horan; Grace M Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2018-12-04       Impact factor: 3.254

7.  Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.

Authors:  B Cohen; J Liu; E Larson
Journal:  J Prev Med Hyg       Date:  2017-12-30

8.  Implementation of government-directed policy in the hospital setting: a modified Delphi study.

Authors:  S M Havers; E Martin; A Wilson; L Hall
Journal:  Health Res Policy Syst       Date:  2019-11-27

9.  Surgical Site Infections: Volume-Outcome Relationship and Year-to-Year Stability of Performance Rankings.

Authors:  Michael S Calderwood; Ken Kleinman; Susan S Huang; Michael V Murphy; Deborah S Yokoe; Richard Platt
Journal:  Med Care       Date:  2017-01       Impact factor: 2.983

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.